Posts

Sniffing women’s tears reduces aggressive behavior in men

Sniffing women’s tears reduces aggressive behavior in men

Dec 21, 2023

New research, publishing December 21st in the open access journal in PLOS Biolog...

Despite use of tecovirimat since the beginning of the 2022 mpox outbreak, few data have been published on its antiviral effect in humans

Despite use of tecovirimat since the beginning of the 2...

Dec 21, 2023

Despite use of tecovirimat since the beginning of the 2022 mpox outbreak, few da...

Society of Women Engineers celebrates Sandia Labs employees

Society of Women Engineers celebrates Sandia Labs emplo...

Dec 21, 2023

ALBUQUERQUE, N.M. — Women engineers at Sandia National Laboratories achieved sig...

Male breast cancer diagnosis fuels groundbreaking treatment tool

Male breast cancer diagnosis fuels groundbreaking treat...

Dec 21, 2023

Doctors diagnosed Christopher Gregg, Ph.D., member of the Nuclear Control of Cel...

FDA receives first-ever MDMA drug application

FDA receives first-ever MDMA drug application

Dec 20, 2023

The timeline for the Multidisciplinary Association for Psychedelic Studies (MAPS...

MABS-139 by Manhattan Biosolutions for Solid Tumor: Lik...

Dec 20, 2023

MABS-139 is under clinical development by Manhattan Biosolutions and currently i...

FLU-SV-mRNA by Curevac for Influenza A Virus, H1N1 Subt...

Dec 20, 2023

FLU-SV-mRNA is under clinical development by Curevac and currently in Phase I fo...

ND-10 ER by Theialife Sciences for Myopia: Likelihood o...

Dec 20, 2023

ND-10 ER is under clinical development by Theialife Sciences and currently in Ph...

Meloxicam fast acting by Viatris for Post-Operative Pai...

Dec 20, 2023

Meloxicam fast acting is under clinical development by Viatris and currently in ...

NNC-05600004 by Novo Nordisk for Liver Diseases: Likeli...

Dec 20, 2023

NNC-05600004 is under clinical development by Novo Nordisk and currently in Phas...

GUB-014295 by Gubra for Obesity: Likelihood of Approval

Dec 20, 2023

GUB-014295 is under clinical development by Gubra and currently in Phase I for O...

UI-059 by Korea United Pharm for Reflux Esophagitis (Ga...

Dec 20, 2023

UI-059 is under clinical development by Korea United Pharm and currently in Phas...

GLB-001 by GluBio Therapeutics for Refractory Acute Mye...

Dec 20, 2023

GLB-001 is under clinical development by GluBio Therapeutics and currently in Ph...

GLB-001 by GluBio Therapeutics for Myelodysplastic Synd...

Dec 20, 2023

GLB-001 is under clinical development by GluBio Therapeutics and currently in Ph...

GLB-001 by GluBio Therapeutics for Relapsed Acute Myelo...

Dec 20, 2023

GLB-001 is under clinical development by GluBio Therapeutics and currently in Ph...

STAT+: Health care industry fights back against crackdowns on health data tracking

STAT+: Health care industry fights back against crackdo...

Dec 19, 2023

Providers say regulators have overstepped their authority and hobbled critical h...